ProCE Banner Events

The Emerging Role of Subcutaneous Injection Options in IO Therapy

The Advancements of Sub Q formulations with IO therapies and their potential impact in Modern Oncology Practice.

Key Takeaways:

  • Interpretation of recent clinical data of Newly Approved Subcutaneous IO Agents.
  • Understand Indications, Appropriate Use, Dosing and Side effects.

This event has expired. No longer available for credits.

Time and location

Tuesday, February 18, 2025

12:15 PM - 1:00 PM Central Time (CT)

Virtual

Sponsored By

Bristol Myers Squibb

Bristol Myers Squibb

1992-US-2500020